HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful cord blood transplantation with reduced-intensity conditioning for childhood cerebral X-linked adrenoleukodystrophy at advanced and early stages.

Abstract
Childhood cerebral ALD is a rapidly progressive and neurodegenerative disorder for which HSCT is the curative therapy if carried out at early stages. We successfully treated two patients of childhood cerebral ALD by CBT with RIC. The proband was a seven-yr-old boy whose brain MRI severity score (Loes score) was 14.5. Unrelated CBT was performed in five wk. To minimize conditioning regimen-related neurotoxicity, the combination of fludarabine (125 mg/m(2)), melphalan (140 mg/m(2)), and 4 Gy of brain-sparing TBI was used. The second patient was a six-yr-old brother of the proband. Four wk after the detection of a single small lesion (Loes score 1), he received unrelated CBT with the same RIC as the proband. In both patients, the engraftment was fast and stable, and severe complications were not observed. Furthermore, gadolinium-enhanced inflammation on brain MRI rapidly disappeared after CBT. Now, 20 and 13 months have passed after CBT, respectively, and both patients are neurologically stable. The RIC we used was sufficient for stable engraftment of cord blood and also tolerable even to the patient with advanced ALD. RIC-CBT should be considered for the patients with cerebral ALD at advanced stages, as well as those at early stages.
AuthorsHidetaka Niizuma, Mitsugu Uematsu, Osamu Sakamoto, Toru Uchiyama, Satoshi Horino, Masaei Onuma, Tetsuro Matsuhashi, Takeshi Rikiishi, Yoji Sasahara, Masayoshi Minegishi, Shigeru Tsuchiya
JournalPediatric transplantation (Pediatr Transplant) Vol. 16 Issue 2 Pg. E63-70 (Mar 2012) ISSN: 1399-3046 [Electronic] Denmark
PMID21834803 (Publication Type: Case Reports, Journal Article)
Copyright© 2011 John Wiley & Sons A/S.
Chemical References
  • Myeloablative Agonists
  • Vidarabine
  • fludarabine
  • Melphalan
Topics
  • Adrenoleukodystrophy (diagnosis, surgery)
  • Brain (pathology)
  • Child
  • Cord Blood Stem Cell Transplantation
  • Humans
  • Male
  • Melphalan (administration & dosage)
  • Myeloablative Agonists (administration & dosage)
  • Severity of Illness Index
  • Transplantation Conditioning (methods)
  • Vidarabine (administration & dosage, analogs & derivatives)
  • Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: